HOUT-30. TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)

INTRODUCTION: TTFields in combination with TMZ showed significant survival benefit for newly diagnosed glioblastoma patients in the EF-14 trial, compared to TMZ standard therapy; independent of MGMT-promotor methylation-status, age and performance status. Recently, the CeTeG trial (NOA-09) demonstra...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Lazaridis, Lazaros, Schäfer, Niklas, Kebir, Sied, Weller, Johannes, Tzaridis, Theophilos-Dimitrios, Scheffler, Björn, Pierscianek, Daniela, Kleinschnitz, Christoph, Stuschke, Martin, Sure, Ulrich, Herrlinger, Ulrich, Glas, Martin
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2018
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217291/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.498
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires